S&P 500

5.346,99

-0,11%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aclarion Inc (ACONW)
Aclarion Inc (ACONW) Notícias

ACONW

Aclarion (ACONW)

Aclarion Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ACONW

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
15/05/2024	16:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACONW	Aclarion Inc
25/04/2024	10:14	GlobeNewswire Inc.	Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
04/03/2024	10:00	GlobeNewswire Inc.	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	NASDAQ:ACONW	Aclarion Inc
27/02/2024	17:22	GlobeNewswire Inc.	Aclarion Announces Closing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
26/02/2024	11:15	GlobeNewswire Inc.	Aclarion Announces Pricing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
05/02/2024	10:00	GlobeNewswire Inc.	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	NASDAQ:ACONW	Aclarion Inc
22/01/2024	10:00	GlobeNewswire Inc.	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	NASDAQ:ACONW	Aclarion Inc
17/01/2024	10:00	GlobeNewswire Inc.	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	NASDAQ:ACONW	Aclarion Inc
08/01/2024	10:00	GlobeNewswire Inc.	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
02/01/2024	14:00	GlobeNewswire Inc.	Aclarion Announces Reverse Stock Split	NASDAQ:ACONW	Aclarion Inc
27/11/2023	10:00	GlobeNewswire Inc.	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	NASDAQ:ACONW	Aclarion Inc
08/11/2023	10:00	GlobeNewswire Inc.	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption	NASDAQ:ACONW	Aclarion Inc
06/11/2023	10:00	GlobeNewswire Inc.	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD	NASDAQ:ACONW	Aclarion Inc
01/11/2023	09:00	GlobeNewswire Inc.	Aclarion Presents at the NIH HEAL Initiative Fall Meeting	NASDAQ:ACONW	Aclarion Inc
25/10/2023	09:30	GlobeNewswire Inc.	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver	NASDAQ:ACONW	Aclarion Inc
24/10/2023	09:45	GlobeNewswire Inc.	Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting	NASDAQ:ACONW	Aclarion Inc
23/10/2023	08:00	GlobeNewswire Inc.	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
02/10/2023	09:00	GlobeNewswire Inc.	Aclarion Provides Updated Investor Presentation and Corporate Update	NASDAQ:ACONW	Aclarion Inc
25/08/2023	17:10	GlobeNewswire Inc.	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report	NASDAQ:ACONW	Aclarion Inc
14/06/2023	12:27	GlobeNewswire Inc.	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI	NASDAQ:ACONW	Aclarion Inc
08/06/2023	08:30	GlobeNewswire Inc.	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting	NASDAQ:ACONW	Aclarion Inc
30/05/2023	08:30	GlobeNewswire Inc.	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic	NASDAQ:ACONW	Aclarion Inc
23/05/2023	08:30	GlobeNewswire Inc.	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD	NASDAQ:ACONW	Aclarion Inc
23/05/2023	08:00	GlobeNewswire Inc.	Aclarion, Inc. Announces Delayed 10-Q Filing	NASDAQ:ACONW	Aclarion Inc
19/05/2023	08:30	GlobeNewswire Inc.	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts	NASDAQ:ACONW	Aclarion Inc
02/05/2023	08:00	GlobeNewswire Inc.	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
28/04/2023	12:20	GlobeNewswire Inc.	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023	NASDAQ:ACONW	Aclarion Inc
24/04/2023	08:00	GlobeNewswire Inc.	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial	NASDAQ:ACONW	Aclarion Inc
07/03/2023	11:19	GlobeNewswire Inc.	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor	NASDAQ:ACONW	Aclarion Inc
15/02/2023	09:00	GlobeNewswire Inc.	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium	NASDAQ:ACONW	Aclarion Inc